Trademarkia Logo

Canada

C$
Trademark Search in Canada
NUCLEXIS

View On IC.GC.CA

NUCLEXIS
REGISTERED

on 12 Mar 2020

Last Applicant/ Owned by

KARYOPHARM THERAPEUTICS INC.

85 Wells Avenue Newton, MA 02459

US

Serial Number

1878132 filed on 18th Jan 2018

Registration Number

TMA1074971 registered on 12th Mar 2020

Registration expiry Date

12th Mar 2030

Correspondent Address

PERRY + CURRIER

1300 YONGE STREETSUITE 500TORONTO

ONTARIO

CA

M4T1X3

NUCLEXIS

Trademark usage description

pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammatory muscle and connective tissue diseases, neurodegenerative diseases Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammatory muscle and connective tissue diseases, neurodegenerative diseases, respiratory diseases, and viral diseases, all the foregoing relating to cell proliferation in humans

Classification kind code

11

Mark Details

Serial Number

1878132

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 191
on 16th Oct 2019		Registration Fee Notice Sent
Submitted for opposition 190
on 16th Oct 2019		Registration Pending
Submitted for opposition 42
on 24th Jul 2019		Advertised
Submitted for opposition 26
on 3rd Jul 2019		Approved
Submitted for opposition 27
on 3rd Jul 2019		Approval Notice Sent
Submitted for opposition 22
on 19th Mar 2019		Search Recorded
Submitted for opposition 20
on 19th Mar 2019		Examiner's First Report
Submitted for opposition 31
on 24th Jan 2018		Formalized
Submitted for opposition 30
on 18th Jan 2018		Filed
Submitted for opposition 1
on 18th Jan 2018		Created